Showing results (81-90 of 395) with videos related to
Sort By:
Pageof 40
International Clinical Psychopharmacology|June 1, 1995
Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patientM Poyurovsky, I Meerovich, A WeizmanPreventive Medicine|December 22, 1999
Impact of treatment for childhood obesity on parental risk factors for cardiovascular diseaseM Golan, A Weizman, M FainaruInternational Clinical Psychopharmacology|December 1, 1996
Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapineM Poyurovsky, H Hermesh, A WeizmanMedical Hypotheses|November 1, 1995
Biophysical shunt theory for neuropsychopathology: Part IY Naisberg, M Avnon, A WeizmanClinical Neuropharmacology|August 1, 1996
Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patientsM Poyurovsky, H Hermesh, A WeizmanLancet (London, England)|April 29, 1989
Ligands specific to peripheral benzodiazepine receptors for treatment of porphyriasY Katz, A Weizman, M GavishThe Israel Journal of Psychiatry and Related Sciences|January 1, 1997
The complexity of molecular genetic research in psychiatric disorders: advances and pitfallsD Gothelf, H Munitz, A WeizmanThe Israel Journal of Psychiatry and Related Sciences|January 1, 1997
Psychometric properties of the K-SADS-PL in an Israeli adolescent clinical populationN Shanee, A Apter, A WeizmanActa Psychiatrica Scandinavica|March 1, 1987
A successful electroconvulsive treatment of neuroleptic malignant syndromeH Hermesh, D Aizenberg, A WeizmanThe American Journal of Psychiatry|December 10, 1999
Obsessive-compulsive disorder in patients with first-episode schizophreniaM Poyurovsky, C Fuchs, A WeizmanPageof 40